
Copenhagen, 28 September 2010
WHO/Europe has released interim recommendations on influenza vaccination for the 2010/2011 winter season.
The document provides advice to the 53 Member States in the WHO European Region related to specific risk groups to be targeted for vaccination, the influenza viruses to be included in vaccination and vaccine safety.
During the 2009/2010 influenza season in the northern hemisphere, the dominant circulating influenza virus was pandemic (H1N1) 2009. Many countries deployed pandemic H1N1 vaccine, targeting risk groups according to the July 2009 recommendations of the WHO Strategic Advisory Group of Experts on Immunization.
Since seasonal influenza viruses A(H3N2) and influenza B are currently co-circulating with pandemic (H1N1) 2009 virus in the southern hemisphere winter season, target groups for vaccination during the upcoming 2010/2011 influenza season in the northern hemisphere must include people at risk of severe outcomes from both seasonal and pandemic influenza.
Priority groups that should be considered for immunization include:
Influenza vaccination should include all three viruses recommended by WHO for inclusion in the influenza vaccines for the northern hemisphere 2010/2011 winter season. Trivalent vaccines should be considered for logistical reasons, to avoid multiple injections, and to address the high burden of seasonal influenza in elderly populations.
Dr Caroline Brown, Technical officer
WHO Regional Office for Europe
Scherfigsvej 8, Copenhagen 2100 Ø, Denmark
Tel.: +45 39 17 12 73
E-mail: CBR@euro.who.int
Ms Zsofia Szilagyi, Communications Adviser
WHO Regional Office for Europe
Scherfigsvej 8, Copenhagen 2100 Ø, Denmark
Tel.: +45 39 17 16 27, +45 24 67 48 46 (mobile)
E-mail: SZZ@euro.who.int
Liuba Negru
External Relations Officer
WHO/Europe
Tel.: +45 39 17 13 44,
+45 20 45 92 74 (mobile)
E-mail: lne@euro.who.int
To sign up for news and press releases, send an email to medialist@euro.who.int